MEDONEFARMA

BORTEZOMIB

PRODUCT DESCRIPTION

Bortezomib is a proteasome inhibitor that stops the action of proteasomes, enzymes that help cancer cells grow. This disrupts cell signaling pathways and can lead to cell cycle arrest, apoptosis, and delayed tumor growth.

CHEMICAL NAME

[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl] boronic acid

Brand Names

Velcade, Bortecad

Category

Oncology (proteasome inhibitor)

DOSAGE FORM

Injection: powder for reconstitution. 3.5mg/vial

INDICATIONS

It is indicated for the treatment of patients with multiple myeloma. It is also indicated for the treatment of adult patients with mantle cell lymphoma.

NDC CODE

43598-0865

STORAGE & SHELF LIFE

  • Shelf life: 3 years (36 months) Unopened
  • Store atcontrolled room temperature 20°C to 25°C (68°F to 77°F); excursions permitted from 15°C to 30°C (59°F to 86°F). Retain in original package to protect from light. 

Anti-infectives

Can’t find what you are looking for?

Please call us. We would love to help.